Search results
Author(s):
Jason Chinitz
,
Dorinna D Mendoza
,
Raymond J Kim
,
et al
Added:
3 years ago
Accurate detection of left ventricular (LV) thrombus affects clinical outcomes and therapeutic management, as thrombus provides a substrate for thromboembolic events and a rationale for anticoagulation. Relative risk (RR) for thrombus development is highest among subjects with systolic heart failure or myocardial infarction (MI), reflecting a link between impaired LV blood stasis, pro-coagulant…
View more
Sahlén Anders Olof
Author
F Aaysha Cader
Research Area(s) / Expertise:
Author
Expertise
Jack Wei Chieh Tan
Research Area(s) / Expertise:
Job title: Head and Senior Consultant
Author
Jonathan Jiunn Liang Yap
Research Area(s) / Expertise:
Job title: Consultant Cardiologist
Author
Author(s):
Suneet Mittal
,
Jonathan S Steinberg
,
Andrew Choi
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The prevalence of AF increases with age;1 one and approximately 2.3 million US adults are currently afflicted with AF, with that number projected to increase to 5.6 million by the year 2050.2
AF typically results in an irregular rhythm with poorly controlled ventricular rate and loss of atrial…
View more
Author(s):
Andrea Elliott
,
Garima Dahyia
,
Rajat Kalra
,
et al
Added:
2 years ago
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more
Author(s):
James R Revenaugh
Added:
3 years ago
This article examines the initial results of the authorÔÇÖs experience to date with percutaneous left ventricular assist (LVA) support of patients in cardiogenic shock, and for temporary left heart support in the setting of high-risk percutaneous intervention. Despite evolving procedural methods, 16 of 18 patients in this study survived to hospital discharge. Intraprocedural complications were…
View more
Author(s):
James N Kirkpatrick
,
Susan E Wiegers
,
J Eduardo Rame
,
et al
Added:
3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart…
View more